Clonal hematopoiesis meets an autoinflammatory disease: the new paradigm of VEXAS syndrome
Martina Fiumara(The San Raffaele Telethon Institute for Gene Therapy), Corrado Campochiaro(Vita-Salute San Raffaele University), Samuele Ferrari(Vita-Salute San Raffaele University), Simone Cenci(Vita-Salute San Raffaele University), Elisa Diral(Vita-Salute San Raffaele University), Fabio Ciceri(Vita-Salute San Raffaele University), Lorenzo Dagna(Vita-Salute San Raffaele University), Alessandro Tomelleri(Vita-Salute San Raffaele University), Marco Matucci‐Cerinic(Vita-Salute San Raffaele University), Gianluca Scorpio(Vita-Salute San Raffaele University), Raffaella Molteni(Vita-Salute San Raffaele University), Gregorio Maria Bergonzi(Vita-Salute San Raffaele University)
Cited by 3
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
|New England Journal of Medicine|2009|1k
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)
|Annals of the Rheumatic Diseases|2009|615
Plasma cells require autophagy for sustainable immunoglobulin production
|Nature Immunology|2013|417